International Ethical Guidelines for Health-related Research Involving Humans [17] |
Council for International Organizations of Medical Sciences (CIOMS), 2016 |
Ethical guideline, applies to activities designed to develop or contribute to generalizable health knowledge |
Universal scope, not defined whom it is addressed to |
Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks [31] |
World Medical Association (WMA), 2016 |
Ethical guideline, applies to the collection, storage and use of identifiable data and biological material beyond the individual care of patients |
Universal scope, primarily addressed to physicians. The WMA encourages others to adopt the principles. |
Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects [37] |
World Medical Association (WMA), 2013 |
Ethical guideline, applies to medical research involving human subjects, including research on identifiable human material and data. |
Universal scope, primarily addressed to physicians. The WMA encourages others to adopt the principles |
Framework for Responsible Sharing of Genomic and Health-Related Data [10] |
Global Alliance for Genomics and Health (GA4GH), 2014 |
A principled and practical framework, applies to the sharing of genomic and health-related data (for biomedical research) |
Universal scope, addressed to all entities or individuals using genomic and health-related data |
The collection, linking and use of data in biomedical research and health care: ethical issues [16] |
The Nuffield Council on Bioethics, 2015 |
Report that sets out ethical principles and recommendations, related to the design and governance of data initiatives and data use for biological and medical research |
United Kingdom / universal, addressed to anyone approaching a data initiative |
Joint statement of purpose—vision, principles, and goals [12] |
Funders of public health research, 2011 |
Joint statement of funders, applies to sharing research data to improve public health |
Universal, addressed to funders and the research community |
Principles and Guidelines for Access to Research Data from Public Funding [18] |
Organisation for Economic Co-operation and Development (OECD), 2007 |
A legally non-binding recommendation, often referred to as soft law. Applies to research data that are gathered using public funds for the purposes of producing publicly accessible knowledge |
Primarily addressed to OECD Member Countries and intended to assist all actors involved when trying to improve the international sharing of, and access to, research data |
Recommendation of the Council on Human Biobanks and Genetic Research Databases [19] |
Organisation for Economic Co-operation and Development (OECD), 2009 |
A legally non-binding recommendation, often referred to as soft law. Provides guidance for the establishment, governance, management, operation, access, use and discontinuation of human biobanks and genetic research databases |
OECD Countries, to be applied as broadly as possible, in particular to aid policy makers and practitioners who are establishing new human biobanks and genetic research databases. Can also usefully be applied to existing biobanks and databases |
Recommendation of the Council on Health Data Governance [22] |
Organisation for Economic Co-operation and Development (OECD), 2017 |
A legally non-binding recommendation, often referred to as soft law. Applies to the access to, and the processing of, personal health data for health-related public interest purposes |
OECD member countries and all levels of government, encourages non-governmental organisations to follow this recommendation |
Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers [9] |
The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA), 2013 |
Joint policy of organisations representing pharmaceutical industries |
Members of EFPIA and PhRMA |